\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ biopsy\ \(441\)\
\-\ radiation\ \(402\)\
\-\ no\\ progression\\ of\\ disease\\ over\\ past\\ 5\\ years\ \(0\)\
\-\ \\â\\€\\¢\\ skull\\ base\\ complex\\ mass\\ extending\\ into\\ sella\\ and\\ suprasellar\\ cistern\\.\ \(0\)\
\-\ \\â\\€\\¢\\ irregular\\ enhancement\\ on\\ mri\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mottled\\ calcification\\ noted\\ within\\ mass\\ on\\ ct\ \(0\)\
\-\ chondrosarcoma\\ of\\ skull\\ base\ \(0\)\
\-\ \\â\\€\\¢\\ chondrosarcoma\ \(3\)\
\-\ \\â\\€\\¢\\ craniopharyngioma\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ chordoma\ \(1\)\
\-\ 17\\ year\\ old\\ boy\\ presents\\ with\\ headache\\ and\\ progressive\\ visual\\ loss\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.3414839403728365\ \(0\)\
\-\ skull\\:\\ 0\\.30215532090986535\ \(0\)\
\-\ base\\:\\ 0\\.2832830055129851\ \(0\)\
\-\ mottled\\:\\ 0\\.2242925663130615\ \(0\)\
\-\ chordoma\\:\\ 0\\.21282213692186258\ \(0\)\
\-\ sella\\:\\ 0\\.19270841436166686\ \(0\)\
\-\ suprasellar\\:\\ 0\\.18267141166631456\ \(0\)\
\-\ cistern\\:\\ 0\\.18080563052584198\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.17991126544685948\ \(0\)\
\-\ progression\\:\\ 0\\.17074197018641826\ \(0\)\
\-\ visual\\:\\ 0\\.158866955202418\ \(0\)\
\-\ disease\\:\\ 0\\.15632319618612048\ \(0\)\
\-\ 17\\:\\ 0\\.1520024328797109\ \(0\)\
\-\ irregular\\:\\ 0\\.1437572939601095\ \(0\)\
\-\ complex\\:\\ 0\\.14346713841982123\ \(0\)\
\-\ progressive\\:\\ 0\\.1426118331556601\ \(0\)\
\-\ mass\\:\\ 0\\.14224950288802166\ \(0\)\
\-\ meningioma\\:\\ 0\\.13952628301641937\ \(0\)\
\-\ calcification\\:\\ 0\\.13294104043782018\ \(0\)\
\-\ biopsy\\:\\ 0\\.13052198701219056\ \(0\)\
\-\ headache\\:\\ 0\\.12836070132963956\ \(0\)\
\-\ boy\\:\\ 0\\.12737553707291344\ \(0\)\
\-\ available\\:\\ 0\\.12633367363292877\ \(0\)\
\-\ extending\\:\\ 0\\.12624833428144192\ \(0\)\
\-\ radiation\\:\\ 0\\.1233938826997429\ \(0\)\
\-\ past\\:\\ 0\\.12120433096844101\ \(0\)\
\-\ years\\:\\ 0\\.1141402301249945\ \(0\)\
\-\ loss\\:\\ 0\\.11344197284040354\ \(0\)\
\-\ on\\:\\ 0\\.11247328284205203\ \(0\)\
\-\ enhancement\\:\\ 0\\.10717547086960662\ \(0\)\
\-\ over\\:\\ 0\\.1035373107858818\ \(0\)\
\-\ metastatic\\:\\ 0\\.1021232838028513\ \(0\)\
\-\ into\\:\\ 0\\.09898255451962212\ \(0\)\
\-\ noted\\:\\ 0\\.09872480249401254\ \(0\)\
\-\ mri\\:\\ 0\\.09558033514050245\ \(0\)\
\-\ presents\\:\\ 0\\.08957347628766128\ \(0\)\
\-\ within\\:\\ 0\\.08575957239093636\ \(0\)\
\-\ and\\:\\ 0\\.07695333116286274\ \(0\)\
\-\ not\\:\\ 0\\.07350869717559338\ \(0\)\
\-\ of\\:\\ 0\\.07287838637179349\ \(0\)\
\-\ ct\\:\\ 0\\.07088940591588265\ \(0\)\
\-\ no\\:\\ 0\\.060551246831851605\ \(0\)\
\-\ year\\:\\ 0\\.05738424071649664\ \(0\)\
\-\ old\\:\\ 0\\.055108735135718435\ \(0\)\
\-\ with\\:\\ 0\\.036460965595142336\ \(0\)\
